This recent publication in Nature Metabolism on preclinical disease models that better reflect Metabolic dysfunction-Associated Steatohepatitis (MASH) in humans aims to increase success of future clinical trials. It highlights a milestone in our collaboration with the LITMUS Project, of which we have been a member for several years. The LITMUS Project is a public-private partnership dedicated to advancing vital research efforts aimed at tackling MASH. Learn more here: https://learn.az/604891Kxn
This collaboration sounds promising for advancing research on Metabolic dysfunction-Associated Steatohepatitis (MASH)! Looking forward to seeing how these preclinical models contribute to clinical trial success.
Hola. Ya se tienen avances contra la diabetes, algún vector o alguna Vacuna mrna
Eco-Beehive.com 👍🏻 likes this
.g
Love this
Excited for the potential these findings hold for future clinical trials and improved patient outcomes!